Outsourced Pharma Editorial Board

 

Charlene

Charlene Banard
Global Head Technical Operations, Cell and Gene Therapy
Novartis

Darren Dasburg
CEO, TreeCo 
CBO, CRISPR Biotech

Thomas Holmes
Global Head, Supply Chain  Amylyx Pharmaceuticals

Marilyn Bruno
CEO
Aequor, Inc.

 

Hugh Wight
Vice President, Technical Operations 
Allena Pharmaceuticals
 

Jana Spes, M.Sc., MBA
(former) Head of Pharmaceutical Development &
Manufacturing Sciences, Ironwood Pharmaceuticals

Takuya Seko
Corporate Officer, Executive Director,
CMC-Production &
CMC Research, 
ONO Pharmaceutical Co., Ltd.

Chuck Forsaith
Senior Director, Security, Pharmaceutical Cargo Security Coalition

James M. Mackay
President and Chief Executive Officer, Aristea Therapeutics

Lisa A. Wyman Vice President, Technical Operations & Quality Acceleron Pharma, Inc.

Todd Mabe
Director
Drug Substance Quality
Merck

Lisa A. Wyman
Vice President, Technical Operations & Quality
Acceleron Pharma, Inc.

Anand Ekambaram
Executive Director Global
Technical Operations, Merck

Vin Kosewski
SVP Manufacturing & Supply Chain Management
Kala Pharmaceuticals, Inc.

Firelli Alonso, Ph.D.
Senior Director, Biotherapeutics & Vaccine Outsourcing
Pfizer

Bikash Chatterjee
President and CSO
Pharmatech Associates

Shawn Eisenberg
Lead Divestments & CMB,
Takeda

Doug Bakan
Executive Vice President,
Technical Operations, Arena Pharmaceuticals, Inc.

Brian James
VP Operations and 
Managing Director,
Rondaxe

Roger Graben

Mark Butchko
Senior Director of Quality Assurance,
Eli Lilly and Company

Roger Graben
President
Vitruvias Therapeutics, Inc.

Sesha Neervannan
Chief Operating Officer
Tarsus Pharmaceuticals, Inc
 

Vimal Gandhi
Director, Global Biosimilar Operations & Strategy
AstraZeneca

Robert P. Discordia, Ph.D
Chief Operating Officer 
Corbus Pharmaceuticals

Ravi Kiron
Head BioPharma External Innovation
EMD Serono, Inc.

David

Michael Mulkerrin
VP, Head of CMC
ADC Therapeutics

David A. Dodd
Chairman, CEO
GeoVax Labs, Inc.

Timothy Scott
Chief Executive Officer 
TEGA Therapeutics

Joe Kim
Vadim Klyushnichenko, Ph.D.
VP Pharmaceutical Development & Quality
California Institute for Biomedical Research (Calibr)

Joseph W. Graskemper
Associate Director, CMC Program Management
Translate Bio

Kim K. Burson, Ph.D.
Head of Quality Assurance and Quality Control
Denali Therapeutics, Inc.